Background: Dengue protease is a two component protease and important for viral replication. Results: An unlinked protease complex containing NS2B regulatory region and NS3 protease domain was obtained.
prophylactic vaccines for treating and/or preventing dengue (4) .
The DENV genome is an 11kb, single-stranded positive-sense RNA. The genomic RNA encodes a polyprotein precursor which is processed proteolytically upon translation to 10 proteins, including three structural proteins (capsid [C] , premembrane [prM] and envelope [Env] ), and seven nonstructural (NS) proteins (NS1, NS2A/B, NS3, NS4A/B, and NS5). The structural proteins form the viral particle. The nonstructural proteins participate in the replication of the RNA genome, virion assembly and attenuation of host antiviral response. Correct processing of these proteins is essential for viral replication and this requires a host signal peptidase and a viral-encoded protease, NS2B/NS3. The N-terminal ~180 amino acids of NS3 (NS3pro) is a serine protease that requires association with at least 40 amino acids of NS2B for activity (5) . Viral-encoded proteases have been successfully targeted for HIV and HCV, which makes the dengue NS2B/NS3 protease an attractive target for therapeutic intervention.
Knowledge of the three-dimensional structure of the target protein is a prerequisite for structurebased rational drug design. Crystal structures of DENV protease in the absence and presence of inhibitors have been determined recently (6, 7) . The NS2B fragment in these structures adopts very different conformations, i.e., without an inhibitor, the C-terminal segment of the NS2B cofactor is dissociated from the active site ("open state") ( Figure 1A) ; while in the presence of inhibitors, it wraps around NS3pro and forms an active, closed conformation, similar to that of the WNV protease ("closed state") ( Figure 1B ). However, in solution, less than 10% of the DENV protease assumes the active, closed conformation (8) , which might suggest an explanation for the lack of success in finding a low nanomolar inhibitor despite intensive efforts (9) . All the proteins used for all the aforementioned structural studies have the approximately 40 amino acids regions of NS2B covalently linked to NS3pro via a Gly 4 -Ser-Gly 4 linker ( Figure 1C ), while in nature the two proteins form the active enzyme through intermolecular association. It is currently unknown whether this linked construct bears any resemblance to the protein complex that is formed to process the viral polyprotein. If it is assumed that the closed form is the appropriate model for the protease, then the linked enzyme is not a suitable model for drug discovery.
In this study, we expressed and purified the NS2B cofactor region and NS3pro from Escherichia coli (E. coli) using a co-expression system in which NS2B and NS3pro were expressed as individual proteins (without any linker) to closely mimic the natural condition ( Figure 1D) . A hexa-histidine tag was introduced at the N-terminus of NS3pro to aid protein purification. We refer to this construct as unlinked protease complex ( Figure 1D ). This unlinked protease complex is catalytically active at neutral pH in the absence of glycerol, and produced dispersed cross-peaks in the HSQC spectrum which enabled us to do a backbone assignment using conventional techniques. More importantly, a paramagnetic relaxation enhancement (PRE) study demonstrated that the NS2B cofactor region of the unlinked DENV protease complex exists predominantly in a similar conformation to that of the linked protease in a complex with an inhibitor. The unlinked DENV protease is therefore useful for the probing of protein-ligand interactions by NMR spectroscopy and guiding structure-based drug design.
EXPERIMENTAL PROCEDURES
Materials-The DNA polymerase and restriction enzymes were purchased from New England Biolabs (Beverly, USA). The FPLC system, gel filtration column, ion exchange columns and PD10 desalting column were purchased from GE (Uppsala Sweden). The SDS-PAGE system, NuPAGE  gels (4-12%), and molecular weight standards were obtained from Invitrogen (Carlsbad, USA) or Bio-rad (Hercules, USA). The protein staining and destaining solutions, protein sample loading buffer and nitrocellulose membrane were purchased from Bio-Rad (Hercules, USA). Ni 2+ -NTA and plasmid extraction and DNA purification kits were obtained from Qiagen (Gmbh, Germany). The 15 NH 4 Cl, 13 C-glucose, deuterated methanol and D 2 O were purchased from Cambridge Isotope Laboratories (Andover, USA). β-D-1-thiogalactopyranoside (IPTG), Dithiothreitol (DTT) and other chemicals were purchased from Sigma-Aldrich (St. Louis, USA).
Expression plasmid construction-The gene encoding the DENV2 NS2B cofactor region (48-100) was amplified by PCR using the full-length NS2B as a template (10) . The resulting PCR product was inserted into the Nde I/Xho I sites of pACYDUET to generate a plasmid pACY-NS2B encoding the NS2B cofactor region without any fusion tags. The gene encoding NS3pro (1-185) was synthesized by GenScript (Piscataway, USA) and inserted into the NdeI and Xho I sites of pETDUET to generate a plasmid pET-NS3pro encoding the NS3pro with an N-terminal hexahistidine tag for purification. Different constructs of NS3pro (14-175, 14-185) were made in a similar fashion. All plasmid insertions were confirmed by DNA sequencing. The linked protease construct with NS2B (48-95) lined to NS3 (1-185) by a Gly 4 -Ser-Gly 4 linker was same as the one used for crystallography (6) .
Expression and purification of unlinked protease complex -The plasmids encoding NS2B cofactor region and NS3pro were co-transformed into E. coli BL21 (DE3) competent cells and cells harboring plasmids were selected on LB plates containing both 34 g/ml of chloramphenicol and 100 g/ml of ampicillin. Protein expression and purification was similar to those previously described (11, 12) . One to three colonies were picked and incubated in 50 ml of M9 medium with antibiotics at 37 C. The overnight culture was transferred into 1 L of M9 medium with antibiotics and induction was performed by adding IPTG to 1 mM final concentration with additional shaking at 240 rpm for 3 hours at 25 C when OD 600 reached 0.6. To purify the recombinant protein, E. coli cells were harvested by centrifugation at 9,000 ×g for 10 min at 4 C. The resulting cell pellets was resuspended in a lysis buffer containing 20 mM sodium phosphate, pH 7.8, 500 mM NaCl and 2 mM -mercaptoethanol. The cells were broken by sonication in an ice bath. Cell lysates were cleared by centrifugation at 40,000 × g for 20 min and the supernatant was mixed with Ni 2+ -NTA resin at 4 C for 1-2 h before being passed through a gravity column. Resin with protein was washed with at least 10 column volumes of washing buffer containing 50 mM sodium phosphate, pH 7.2, 1 M NaCl, 10 mM imidazole and 2 mM -mercaptoethanol to remove non-specific proteins binding to the resin. Protein was eluted with an elution buffer containing 500 mM imidazole, pH 6.5, 500 mM NaCl and 2 mM -mercaptoethanol. 15 (13) . Protease was then purified as described above and analyzed by NMR spectroscopy.
Ion exchange and gel filtration chromatography-Purified protease from the Ni 2+ -NTA column was loaded onto a Superdex 200 column for further purification. The gel filtration buffer contained 20 mM Tris-HCl at a pH of 7.8, 150 mM NaCl and 2 mM DTT. Gel filtration was run at 8 C with a flow rate of 0.5 ml/min. The fractions containing protease was buffer exchanged to buffer A containing 20 mM sodium phosphate at a pH of 6.5, 10 mM NaCl, and 1 mM DTT, using a PD10 desalting column. The sample was loaded onto a Hitrap SP HP column equilibrated with buffer A. Protease was eluted with increasing concentrations of NaCl to 1 M. Some contaminating protein from E. coli that migrates at the similar position to that of NS3pro was removed in this step (14) . The purity of the protease was analyzed using SDS-PAGE. All the proteins were purified more than 90% purity confirmed by SDS-PAGE and mass spectrometry (MS) and used for further studies.
Protease activity assay-DENV protease activity assays were performed in 384-well plates. The enzyme activity was measured in an assay buffer that contained 10 mM Tris-HCl, pH 8.5, 20% glycerol and 1 mM CHAPS in a final volume of 50 µl as previously described (15) . The protease specific, fluorophore-tagged substrate Bz-nKRR-AMC was added in the protease buffer to 20 M concentration. Substrate cleavage was monitored after addition of protease. The increase in fluorescence (excitation 380 nm, emission 450 nm) was continuously monitored on a Tecan Safire 2 microplate reader at room temperature. Kinetic studies using TTNTRR-AMC peptide substrate were performed as described previously (15) . Briefly, 20 nM unlinked protease complex was incubated with various concentration of substrate at 37 C in a buffer containing 50 mM Tris-HCl, pH 7.5, 0.001% Triton X-100 and 0.5 mM EGTA. The proteolytic reaction was monitored as described above. Initial fluorescence velocities (relative fluorescence units per minute) were converted to M•S -1 from a standard AMC calibration curve. The progression curves were fitted into a Michaelis-Menten equation by nonlinear regression using GraphPad Prism (Graphpad).
Peptide aldehyde inhibitor synthesis sand purification -The peptide Bz-Nle-Lys-Arg-Arg-H (Bz-nKRR-H) with a C-terminal aldehyde moiety was synthesized according to a previous report (16) and purified by reverse-phase HPLC (Shimadzu, Japan) using acetonitrile and water solvent.
NMR data acquisition-Purified protease was buffer exchanged to an NMR buffer that contained 20 mM HEPES at a pH of 7.3 and 2 mM DTT. The sample was concentrated to 0.2-1.0 mM and transferred to a 3 mm or 5 mm NMR tube for NMR data acquisition. All the spectra were acquired at 298 K on a Bruker Avance II 600 or 700 MHz spectrometer equipped with a tripleresonance cryoprobe (Bruker). Spectra were processed by Topspin 2.1 (Bruker) and NMRPipe (17) N NOEs were obtained using two datasets that were collected with and without initial proton saturation for a period of 3 s. The spectra were processed and analyzed as previously described (22) .
Spin labeling -Unlinked proteases with serine to cysteine mutations (S171/C, S75 (NB2B)/C) were made by site-directed mutagenesis and purified in the presence of 2 mM β-Mercaptoethanol. The 1-oxyl-2,2,5,5-tetramethyl-Δ3-pyrroline-3-methyl-methanethiosulfonate (MTSL) was used for the spin labeling. A 0.1 mM solution of sample was prepared in the NMR buffer. MTSL was dissolved in methanol to make a 100 mM stock solution. MTSL was slowly added to protein solution to 2 mM concentration. The mixture was gently stirred at 37 C for 1 h and left at room temperature overnight. The mixture was buffer exchanged to the NMR buffer using a PD10 column to remove excess MTSL. The 15 N-HSQC spectra of spin-labeled sample in the absence and presence ascorbic acid were acquired and compared as described above.
Thermal shift assay -The thermal stability of the linked and unlinked proteases were assessed using a thermofluor assay as previously described (22) . Assay samples consisting of 5 M protein, Sypro Orange dye in phosphate buffer (20 mM sodium phosphate, pH 7.0, 150 mM NaCl and 2 mM DTT) were subjected to an increase in temperature from 20 C to 95 C in 0.5 C increments. The experiment was performed on a real time PCR machine with fluorescent readings taken at each temperature increment. The fluorescent measurement were plotted using Graphpad Prism version 5.03 (Graphpad) and melting curves for the two proteins were generated.
RESULTS
Purification of linked and unlinked proteases -The standard linked protease as shown in Figure  1C was over-expressed and purified for our NMR studies ( Figure S1 ). Previous attempts to study the solution structure of this protein by conventional NMR techniques were unsuccessful due to the broad NMR signals and overlapping (23) . A recent NMR study of this linked protease using pseudocontact shifts (PCS) with introduction of paramagnetic lanthanide tags was reported and only assignments for the protease in a complex with an inhibitor was achieved (23, 24) . To our best knowledge, the assignments for the linked, inhibitor-free DENV protease have so far not been achieved. Due to the significant chemical shift difference observed for the linked protease in the absence and presence of an inhibitor (23) , it is hard to use this construct to screen potential protease inhibitors using HSQC-type experiments by NMR. As NS2B and NS3 exist naturally as individual proteins after post-translational processing in the host cell, we decided to coexpress the NS2B cofactor region and NS3pro in E. coli cells without a linker to find out if we could develop a construct more suitable for NMR studies.
Simple mixing of the purified NS2B cofactor region and NS3pro was not possible since NS3pro alone was not soluble when expressed in E. coli. Thus, we decided to use a co-expression system to obtain both fragments in E. coli ( Figure S1, S2) . The presence of the NS2B cofactor region in E. coli promotes the folding of NS3pro. An Nterminal hexa-histidine tag was introduced to the N-terminus of NS3pro, which enable us to purify the unlinked protease complex using affinity chromatography. With this strategy, different constructs were made and purified from E. coli ( Figure S1 ). A further ion exchange step was used to remove contaminating proteins with molecular weights similar to that of NS3pro ( Figure S1 ). All constructs were stable at room temperature except one (1-165) which precipitated after purification ( Figure S1 ). Purified proteins were confirmed by MS analysis ( Figure S3 ).
Enzymatic activity of the unlinked protease complexes-The protease activities of the unlinked purified protease complexes were assayed using the Bz-nKRR-AMC as a substrate and compared to the results of the linked protein. The linked protease exhibited catalytic activity similar to that of unlinked protease complexes (Table 1) . A previous study showed that the linked protease possessed the highest enzymatic activity using small peptide substrates at a pH of 8.5, in the presence of glycerol and detergent (25) .
Effects of pH, addition of salt, glycerol and detergent on the purified unlinked protease complex were also explored to determine the optimal proteolytic conditions. We found that some detergents such as Brij35
 and CHAPS enhanced protease activity of the unlinked protease (data not shown). Presence of salt (NaCl or KCl) in the assay buffer inhibited the protease activity, mirroring the results of linked protease from DENV and WNV (25, 26) . Interestingly, the unlinked protease complex maintained good protease activity at physiological pH (pH 7.3) in the absence of 20% glycerol, conditions that are suitable for NMR studies. We also tested the enzyme activity using the fluorogenic hexapeptide substrate TTNTRR-AMC, a natural enzyme cleavage site between NS4B and NS5. This substrate was efficiently cleaved in a buffer containing 50 mM Tris-HCl, pH 7.5, 0.001% Triton X-100 and 0.5 mM EGTA with the kinetic parameters, K m = 40.9 ± 2.8 M; k cat = 6.03 ± 0.4 S -1 ; k cat /K m = 147,910 ± 12931 M -1 S -1 . NMR spectra of purified protease -The linked protease at pH 6.5 produced a 15 N-HSQC spectrum with severe peak overlaps and line broadening, which was not caused by denaturation of the protease because the protease still possess protease activity and circular dichroism spectroscopy of this linked protease indicated it was folded under this condition ( Figure S4 ). The NMR spectrum of the linked protease with less cross-peaks than predicted very likely due to the conformational flexibility of this protease construct, which was also observed in the previous study and was similar to WNV protease (8, 23, 27, 28) (Figure 2A) . Surprisingly, removal of the Gly 4 -Ser-Gy 4 linker from the constructs and co-expression of NS2B and NS3 as an unlinked protein complex greatly improved the quality of the 15 N-HSQC spectra ( Figure 2B) . A 15 N-HSQC spectra comparison between NS3 of different lengths revealed no observable chemical shift perturbations (Figure S5 ), suggesting that all the constructs had similar structures. Using the current data, the unlinked protease complex containing the NS2B cofactor region (48-100) and NS3pro (14-185) was selected for further study due to its higher yield during protein purification and shorter amino acid sequence.
Backbone resonance assignments and secondary structure analysis -To aid resonance assignment, selectively labeled proteases with 15 N-labeled Ala, His, Met, Arg, Thr, Ser, Phe, and Leu were prepared ( Figure S6 ). The backbone resonance assignments for the unlinked protease complex at pH 7.3 were achieved using conventional NMR methods. We obtained ~80% assignment for backbone amide protons and amide nitrogen (Figure 3 ). Other backbone assignments have been obtained for 85% of Cα, 81% of C' and 78% of Cβ. There were some cross-peaks in the 15 N-HSQC spectrum that could not be unambiguously assigned (Figure 2 ), which may due to the dynamic nature of these residues. Secondary structural analysis was carried out using TALSO+ (20) and CSI with Cα chemical shift deviations from random coil values ( Figure  S7 ). For NS3pro, the secondary structure is similar to that determined by X-ray crystallography (6) . For the NS2B cofactor, the Nterminal fragment (NTF) adopted a -sheet structure, consistent with the X-ray crystal result (6) . In the solid state, the inhibitor-free NS2B Cterminal fragment (CTF) adopted a helical structure, which may have been caused by crystal packing effects (6) . In our work with the unlinked protease complex, no α-helical structure was identified in NS2B ( Figure S6 ), but CTF residues of NS2B were observed to have a tendency to form β-sheet structures, indicating that NS2B may exist in a conformation similar to the closed form of the linked protease ( Figure S7) .
Probing protease-inhibitor interactions by NMR -For the linked protease, significant changes such as new cross-peaks appearing in the 15 N-HSQC spectrum were observed in the presence of an inhibitor, which may due to stabilization of the closed form of the protease (23) . We compared the 15 N-HSQC spectra of the unlinked protease complex in the absence and presence of BznKRR-H inhibitor (7, 16) . Chemical shift perturbation was observed but no new peaks appeared (Figure 4) . The interaction between unlinked protease complex and the peptide inhibitor was confirmed using a thermal shift assay ( Figure 5 ). The 50% inhibitory concentrations (IC 50 s) of the peptide inhibitor to the linked and un-linked protease were 6.49 ± 1.28 M and 15.15 ± 4.36 M, respectively ( Figure S8) .
Relaxation analysis for the unlinked proteaseThe flexibility of the unlinked protease complex was probed by measuring the R 1 , R 2 relaxation rates and the { 1 H}-15 N steady-state NOE using a uniformly 15 N-labeled protease (29) . For NS3pro, the N-terminal residues (14-16) and C-terminal residues (174 to 185) were found to be unstructured with lower R 2 and higher R 1 values (Figure 6 ), consistent with the steady-state NOE result ( Figure 6 ). The correlation times for molecular reorientation based on R 1 and R 2 for NS3pro and NS2B cofactor region were ~12 ns and ~10 ns, respectively. These values were in the expected range for a protein with a molecular weight of ~20 kDa, suggesting that the NS2B cofactor region and NS3pro formed a monomeric complex in solution.
PRE experiment -Paramagnetic relaxation enhancement (PRE) has been widely used to probe conformational equilibriums (30, 31) . PRE was used to understand the conformation of NS2B in linked WNV protease (8) . As wild-type DENV protease does not posses cysteines, two mutations (S171/C and S75/C (NS2B)) were made to enable the spin labeling. Enzymatic assay indicated that these mutations were still active (Table 1) . A comparison of the 15 N-HSQC spectra between wild-type and S/C mutations of the unlinked protease complex was found to be similar, suggesting the mutations did not alter the structure of the protease ( Figure S9 ). The results from the S171C were ambiguous because the S171 is located in a flexible region ( Figure S9 ).
The DENV crystal structure showed that residues such as G121, G148, G114, T122 and T156 were remote from S75 (6) in the open linked form ( Figure 7A , C) but were in proximity in the closed conformation ( Figure 7B, D) (7) . An analysis of the PRE data on our unlinked S75C complex revealed that G121, G148, G114, T122 and T156 were in close proximity to S75, indicating that the unlinked protease complex adopted a conformation similar to the closed form of the linked protein in the presence of an inhibitor ( Figure 7B ).
DISCUSSION
The DENV NS2B-NS3 complex is a trypsinlike serine protease involved in viral proteolytic processing and plays a crucial role in viral survival and replication. To date, efforts to make a catalytically-active enzyme complex involved expressing the NS2B co-factor region (~40 residues) tethered to NS3Bpro (~180 residues) by a Gly 4 -Ser-Gly 4 linker. This linker, although not found naturally in the protease complex, was introduced to stabilize the NS2B-NS3pro complex without which the enzyme undergoes selfproteolysis after being expressed (5, 25, 32) . NMR experiments conducted on the linked protease construct have met with little success due to severe peak broadening, hindering research efforts (23) .
In this study, we co-expressed and purified several unlinked protease complexes from E. coli. The enzymatic assay indicated that the unlinked protease complexes exhibited similar enzymatic activity to the linked protease (Table 1) . In contrast to the linked protease which required basic pH and co-solvents, the optimal activity of the unlinked protease complex was achieved at pH 7.5 in the absence of glycerol. The unlinked protease complex in our study produced well dispersed NMR cross-peaks ( Figure 2B ). It is surprising that the removal of such a short, unstructured linker (8) improved the NMR spectrum significantly ( Figure 2B ). One possible explanation is that the linker induces conformational dynamics that are absent in the unlinked complex. The removal of the Gly 4 -SerGly 4 linker may make the unlinked protease complex more stable, resulting in a well-resolved NMR spectrum.
As a potential drug target, much effort has been invested into screening for DENV protease inhibitors (33) (34) (35) (36) (37) (38) (39) (40) (41) . The linked DENV protease construct has been widely utilized for in vitro biochemical assays and in silico compound screening. Although the linked protease exhibited a resolved 15 N-HSQC spectrum in the presence of small-molecular inhibitors, significant chemical shift perturbations were observed and new peaks were observed (23) , making it difficult to map the protein-inhibitor interface. Using our novel unlinked protease complex, we were able to obtain dispersed cross-peaks in an HSQC spectrum and only chemical shift perturbations were observed in the presence a potent inhibitor ( Figure 5 ). This facilitates the mapping of the binding site for inhibitors and the generation of structure activity relationships using NMR.
Using our unlinked protease construct, we successfully achieved backbone assignment using conventional NMR techniques (Figure 3) . Secondary structural analysis on NS3pro was in good agreement with structures determined by Xray crystallography (6,7) ( Figure S7 ). Relaxation analysis showed that the N-terminal residues (14-18) and the C-terminal residues (174 to 185) of NS3pro are flexible (Figure 6 ). In the solution structure of the unlinked protease, the NTF of NS2B adopts a stable -sheet that interacts with NS3pro. In contrast, the CTF of NS2B was found to be more flexible with a tendency to form a -sheet conformation ( Figure S6 ).
Previous structural studies suggested that proteases from DENV or WNV existed in an equilibrium between open and closed forms and this equilibrium was driven toward the closed form in the presence of an inhibitor (7, 8) . In this work we showed that the unlinked protein complex is similar to the closed form of the linked protease. Our hypothesis is supported by the following findings: (a) the appearance of crosspeaks from the residues such as G82 from NS2B that was only observed for linked protease in the presence of an inhibitor ( Figure 3) (8, 23, 24) ; (b) relaxation analysis showed that the tumbling time of NS2B CTF residues such as G82 was close to those from NTF (Figure 2) , indicating it forms a close contact with NS3pro ( Figure 8) ; (c) using a PRE experiment, close contacts between residue S75 from NS2B and residues such as G114 and G121 from NS3 were observed ( Figure 7) (7) . In addition, in the presence of the potent active-site inhibitor Bz-nKRR-H, only chemical shift perturbations were observed.
In conclusion, we co-expressed and purified an unlinked, enzymatically-active DENV protease complex suitable for NMR structural studies. Our results revealed that the protease complex existed predominantly in a confirmation that is similar to the closed form of the linked protease. We believe our unlinked construct provides a more realistic model for biochemical assays, inhibitor screening and modeling and would serve as a valuable tool in the development of DENV protease inhibitors. N-HSQC spectrum of an unlinked protease complex containing NS2B co-factor region (48-100) and NS3pro (1-185). These two proteases were expressed and purified to 0.2 mM concentration in the NMR buffer that contained 20 mM sodium phosphate, at pH 6.5, 150 mM NaCl and 1 mM DTT. The protein structure was obtained from protein data bank (PDB) with id of 2FOM (6) . The CTF and NTF of NS2B are colored cyan and blue, respectively. B. Crystal structure of the linked protease from DENV-3. The reside 82 from NS2B is represented by a sphere. 
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